Survival Outcomes in Patients With Advanced Hepatocellular Carcinoma Treated With Drug-Eluting Bead Chemoembolization is organized by American Roentgen Ray Society (ARRS) and will be held during Jan 23, 2015 - Jan 22, 2021.

The target audience for this medical event is readers of the AJR, radiologists, radiologists-in-training, and other health professionals with an interest in the treatment of hepatocellular carcinoma. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.

Conference Objectives are :
• Understand the criteria for tumor staging and treatment of hepatocellular carcinoma.
• Understand the treatment options and survival patterns of advanced hepatocellular carcinoma.

Additional details will be posted as soon as they are available.

Intended Audience

Vascular and Interventional Radiology, Gastrointestinal Endoscopy, Oncology, Hepatology

Activity Payment Details

Activity Fee : USD $40.00

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


American Roentgen Ray Society (ARRS)

View Organizer Details


(866) 940-2777, (703) 729-3353